Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adjuvant Chemotherapy”

1,314 trials

Showing 20 of 1,314 results

Large-scale testing (Phase 3)Study completedNCT01317108
What this trial is testing

Prognostic and Predictive Impact of uPA/PAI-1

Who this might be right for
Breast Cancer
Universitätsklinikum Hamburg-Eppendorf 689
Large-scale testing (Phase 3)UnknownNCT00301925
What this trial is testing

Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery

Who this might be right for
Breast Cancer
Institute of Cancer Research, United Kingdom 4,400
Large-scale testing (Phase 3)Study completedNCT01661790
What this trial is testing

Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer

Who this might be right for
Malignant Pleural Effusion
Chinese PLA General Hospital 72
Not applicableUnknownNCT05362825
What this trial is testing

Surgery Outcome Treated by Neo-adjuvant Combination of Oxaliplatin, Irinotecan, Folinic Acid and Fluorouracil (FOLFOXIRI) Regimen in Synchronous Liver Limited Metastasis Colorectal Cancer

Who this might be right for
Liver Metastasis Colon CancerSynchronous Neoplasm
Cho Ray Hospital 89
Not applicableActive Not RecruitingNCT04416490
What this trial is testing

Oxaliplatin Adjuvant Chemotherapy After Curative Resection of Primary Colon Cancer

Who this might be right for
Stage II Colon CancerStage III Colon Cancer
Boryung Pharmaceutical Co., Ltd 2,013
Large-scale testing (Phase 3)Not Yet RecruitingNCT07005557
What this trial is testing

Chemo-free in Older (≥65) Node-Positive ER+/HER2- Breast Cancer

Who this might be right for
Breast CancerAdjuvant Therapy
Fudan University 1,244
Large-scale testing (Phase 3)Study completedNCT02172976
What this trial is testing

Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas Carcinoma

Who this might be right for
Resectable Prancreas Carcinoma
Krankenhaus Nordwest 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT06094140
What this trial is testing

NEO-adjuvant Chemo-immunotherapy in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Australasian Gastro-Intestinal Trials Group 20
Not applicableStudy completedNCT01304251
What this trial is testing

Effects of Short-term Fasting on Tolerance to Chemotherapy

Who this might be right for
Breast Cancer
Leiden University Medical Center 13
Large-scale testing (Phase 3)UnknownNCT02958111
What this trial is testing

Single-agent Capecitabine as Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 406
Large-scale testing (Phase 3)Study completedNCT02586025
What this trial is testing

Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive Breast Cancer to Evaluate Treatment With Trastuzumab Plus (+) Pertuzumab + Docetaxel Compared With Trastuzumab + Placebo + Docetaxel

Who this might be right for
Breast Cancer
Hoffmann-La Roche 329
Large-scale testing (Phase 3)Study completedNCT01216111
What this trial is testing

Adjuvant Platinum and Taxane in Triple-negative Breast Cancer (PATTERN)

Who this might be right for
Triple Negative Breast Cancer
Fudan University 647
Testing effectiveness (Phase 2)Active Not RecruitingNCT03756298
What this trial is testing

Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
National Cancer Center, Korea 284
Large-scale testing (Phase 3)Ended earlyNCT00193726
What this trial is testing

Estrogen Priming to Increase the Efficacy of Adjuvant Chemotherapy in Operable Breast Cancer

Who this might be right for
Breast Cancer
Sudeep Gupta 273
Large-scale testing (Phase 3)Not Yet RecruitingNCT07407517
What this trial is testing

Adjuvant Intensification for LAR

Who this might be right for
Breast Cancer FemalesTriple Negative Breast Cancer (TNBC)
Fudan University 904
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06942663
What this trial is testing

Randomized Phase II Trial Evaluating DFS in The Absence of an Adjuvant Component of Perioperative Chemotherapy in Patients With Gastric Cancer

Who this might be right for
Gastric Cancer
Nizhny Novgorod Regional Clinical Oncology Center 228
Not applicableStudy completedNCT02365935
What this trial is testing

4 Versus 6 Courses of Adjuvant Chemotherapy in LACC Patients Previously Treated With NACT Plus Radical Surgery

Who this might be right for
Uterine Cervical Neoplasms
Campus Bio-Medico University 215
Not applicableWithdrawnNCT03946033
What this trial is testing

Impact of Immunoscore Colon Test on Adjuvant Therapeutic Strategy in Non-Metastatic Colon Cancer

Who this might be right for
Colonic Neoplasms
UNICANCER
Large-scale testing (Phase 3)Study completedNCT00309543
What this trial is testing

Randomized Trial on Adjuvant Chemotherapy in Colon Carcinoma Dukes B

Who this might be right for
Colon Cancer Stage II
Austrian Breast & Colorectal Cancer Study Group 636
Large-scale testing (Phase 3)Looking for participantsNCT06293625
What this trial is testing

Personalising and Refining Neo-adjuvant Chemotherapy in Locally Advanced but Resecable Colon Cancer in the Elderly of 70 Years Old or More

Who this might be right for
Colon Cancer
Centre Hospitalier Universitaire Dijon 150
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation